Aa
Aa
A
A
A
Close
Avatar universal

Triple combination treatment

Pt on Incivek/Peg/Riba tx had to D/C Incivek at the end of first week of tx, secondary to progressively worsening generalizing rash and systemic symptoms. She continues Peg/Riba and she is improving at wk 2 . It is feasible to switch to Victrelis and when to introduce it? HCV RNA  is pending, the rest of the labs nl.
4 Responses
Sort by: Helpful Oldest Newest
Avatar universal
My husband's hepatologist said that if triple therapy with Incivek does not work for him, they cannot treat him with Boceprevir because they are too similar and wouldn't work.  She said the next step would be to wait for the next round of new drugs.  He is a partial responder, not a non responder, to previous treatments.
Advocate 1955
Helpful - 0
Avatar universal
Yes do talk with a doctor that has worked with both of these drugs, this is what i found.

Currently, there is no evidence to support switching from one PI to the other if treatment is not successful. The safety and efficacy of switching to the other PI because of a drug-specific adverse event also has not been established. Likewise, a patient for whom one PI was not successful should not be retreated with a regimen containing the other PI.

But that doesn't mean its not possible to treat with boceprevir in the future as it also states,

Fear of resistance should not be a reason to withhold telaprevir or boceprevir from a patient who is expected to benefit from therapy because resistance can be minimized as long as stopping rules are adhered to and it does not necessarily disqualify patients from future therapeutic options.

http://www.clinicaloptions.com/Hepatitis/Treatment%20Updates/HCV%20New%20Agents/Module/Practical_Guide/Pages/Page%205.aspx.

Also we do have one here that treated with incivek and is now treating with victrelis...... rockymoe....... might send a pm to her.

HONDA.............. Your doctor either mispoke or is wrong about that, many naive people is and have been treating with Inc.



Helpful - 0
250701 tn?1320974765
I thought Incivek was for non responders. PPl who have tried became neg and after treatment it came back. At least that is what my dr. told me. I was on the Peg/Ribo my bloodwork came back neg for 10 months then when I got off of the treatment it came back. :(   I don't see why they couldn't just add the Victrelis to her treatment. You would have to ask the Dr. if it is feasible.
Helpful - 0
1747881 tn?1546175878
This is a very good question but one that should be discussed with a doc that has expirience using the new PI's.
From what I have read once the PI has been stopped it should not be reintroduced as far as cross resistance issue's between the 2 PI's I believe there might be a probem, like I said it is something that should be discussed with a doc with exp using the new PI's
PI= protease inhibitor=Incivek and victrelis
Helpful - 0
Have an Answer?

You are reading content posted in the Hepatitis C Community

Top Hepatitis Answerers
317787 tn?1473358451
DC
683231 tn?1467323017
Auburn, WA
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Answer a few simple questions about your Hep C treatment journey.

Those who qualify may receive up to $100 for their time.
Explore More In Our Hep C Learning Center
image description
Learn about this treatable virus.
image description
Getting tested for this viral infection.
image description
3 key steps to getting on treatment.
image description
4 steps to getting on therapy.
image description
What you need to know about Hep C drugs.
image description
How the drugs might affect you.
image description
These tips may up your chances of a cure.
Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.